Annual EBIT
-$9.62 M
+$14.00 M+59.28%
01 July 2024
Summary:
Enzo Biochem annual earnings before interest & taxes is currently -$9.62 million, with the most recent change of +$14.00 million (+59.28%) on 01 July 2024. During the last 3 years, it has fallen by -$10.31 million (-1490.17%). ENZ annual EBIT is now -204.25% below its all-time high of $11.48 million.ENZ EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$2.45 M
-$1.10 M-81.13%
01 July 2024
Summary:
Enzo Biochem quarterly earnings before interest & taxes is currently -$2.45 million, with the most recent change of -$1.10 million (-81.13%) on 01 July 2024. Over the past year, it has increased by +$1.95 million (+44.40%). ENZ quarterly EBIT is now -142.46% below its all-time high of $5.76 million, reached on 31 October 2002.ENZ Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$9.62 M
+$9.81 M+50.48%
01 July 2024
Summary:
Enzo Biochem TTM earnings before interest & taxes is currently -$9.62 million, with the most recent change of +$9.81 million (+50.48%) on 01 July 2024. Over the past year, it has increased by +$14.78 million (+60.57%). ENZ TTM EBIT is now -173.34% below its all-time high of $13.12 million, reached on 31 January 2003.ENZ TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENZ EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +59.3% | +44.4% | +60.6% |
| 3 y3 years | -1490.2% | -344.9% | -867.1% |
| 5 y5 years | +60.2% | +62.4% | +63.0% |
ENZ EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1490.2% | +59.3% | -365.4% | +80.0% | -867.1% | +60.6% |
| 5 y | 5 years | -1490.2% | +68.3% | -161.1% | +80.0% | -1490.6% | +68.3% |
| alltime | all time | -204.3% | +68.3% | -142.5% | +80.0% | -173.3% | +68.3% |
Enzo Biochem EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | -$9.62 M(-59.3%) | -$2.45 M(+81.1%) | -$9.62 M(-50.5%) |
| Apr 2024 | - | -$1.35 M(-5.1%) | -$19.43 M(-12.3%) |
| Jan 2024 | - | -$1.42 M(-67.6%) | -$22.17 M(-9.2%) |
| Oct 2023 | - | -$4.40 M(-64.1%) | -$24.40 M(+3.3%) |
| July 2023 | -$23.62 M(+95.4%) | -$12.26 M(+199.9%) | -$23.62 M(+10.2%) |
| Apr 2023 | - | -$4.09 M(+11.8%) | -$21.43 M(+8.5%) |
| Jan 2023 | - | -$3.66 M(+1.0%) | -$19.74 M(+30.2%) |
| Oct 2022 | - | -$3.62 M(-64.0%) | -$15.16 M(+25.4%) |
| July 2022 | -$12.09 M(-1847.4%) | -$10.06 M(+318.9%) | -$12.09 M(+25.9%) |
| Apr 2022 | - | -$2.40 M(-360.5%) | -$9.61 M(+135.7%) |
| Jan 2022 | - | $922.00 K(-267.6%) | -$4.08 M(+309.5%) |
| Oct 2021 | - | -$550.00 K(-92.7%) | -$995.00 K(-243.8%) |
| July 2021 | $692.00 K(-102.3%) | -$7.58 M(-342.2%) | $692.00 K(-137.5%) |
| Apr 2021 | - | $3.13 M(-21.8%) | -$1.84 M(-85.6%) |
| Jan 2021 | - | $4.00 M(+252.0%) | -$12.77 M(-43.8%) |
| Oct 2020 | - | $1.14 M(-111.2%) | -$22.72 M(-25.2%) |
| July 2020 | -$30.37 M(+25.5%) | -$10.11 M(+29.7%) | -$30.37 M(+18.5%) |
| Apr 2020 | - | -$7.80 M(+31.1%) | -$25.62 M(+5.8%) |
| Jan 2020 | - | -$5.95 M(-8.6%) | -$24.22 M(-6.9%) |
| Oct 2019 | - | -$6.51 M(+21.3%) | -$26.02 M(+7.6%) |
| July 2019 | -$24.19 M(+243.8%) | -$5.37 M(-16.2%) | -$24.19 M(+4.3%) |
| Apr 2019 | - | -$6.40 M(-17.4%) | -$23.19 M(+29.3%) |
| Jan 2019 | - | -$7.75 M(+65.7%) | -$17.94 M(+55.9%) |
| Oct 2018 | - | -$4.68 M(+7.1%) | -$11.51 M(+63.5%) |
| July 2018 | -$7.04 M(+379.0%) | -$4.37 M(+280.7%) | -$7.04 M(+151.9%) |
| Apr 2018 | - | -$1.15 M(-12.8%) | -$2.79 M(+100.4%) |
| Jan 2018 | - | -$1.32 M(+535.7%) | -$1.39 M(+81.0%) |
| Oct 2017 | - | -$207.00 K(+66.9%) | -$770.00 K(-47.6%) |
| July 2017 | -$1.47 M(-63.4%) | -$124.00 K(-149.0%) | -$1.47 M(-31.3%) |
| Apr 2017 | - | $253.00 K(-136.6%) | -$2.14 M(-34.7%) |
| Jan 2017 | - | -$692.00 K(-23.6%) | -$3.27 M(-25.0%) |
| Oct 2016 | - | -$906.00 K(+14.2%) | -$4.36 M(+8.6%) |
| July 2016 | -$4.02 M(+3.7%) | -$793.00 K(-10.1%) | -$4.02 M(-7.5%) |
| Apr 2016 | - | -$882.00 K(-50.5%) | -$4.34 M(-4.0%) |
| Jan 2016 | - | -$1.78 M(+216.9%) | -$4.52 M(+18.4%) |
| Oct 2015 | - | -$562.00 K(-49.8%) | -$3.82 M(-1.4%) |
| July 2015 | -$3.88 M(-38.7%) | -$1.12 M(+5.6%) | -$3.88 M(+6.4%) |
| Apr 2015 | - | -$1.06 M(-1.5%) | -$3.64 M(-15.8%) |
| Jan 2015 | - | -$1.08 M(+74.3%) | -$4.33 M(-18.5%) |
| Oct 2014 | - | -$618.00 K(-30.3%) | -$5.31 M(-16.1%) |
| July 2014 | -$6.33 M(-52.0%) | -$887.00 K(-49.1%) | -$6.33 M(-19.6%) |
| Apr 2014 | - | -$1.74 M(-15.2%) | -$7.87 M(-21.5%) |
| Jan 2014 | - | -$2.06 M(+25.5%) | -$10.02 M(-19.9%) |
| Oct 2013 | - | -$1.64 M(-32.5%) | -$12.52 M(-4.9%) |
| July 2013 | -$13.17 M(+7.8%) | -$2.43 M(-37.8%) | -$13.16 M(-6.6%) |
| Apr 2013 | - | -$3.90 M(-14.3%) | -$14.10 M(+10.3%) |
| Jan 2013 | - | -$4.55 M(+99.3%) | -$12.77 M(+16.1%) |
| Oct 2012 | - | -$2.28 M(-32.0%) | -$11.00 M(-15.9%) |
| July 2012 | -$12.21 M(+32.5%) | -$3.36 M(+30.2%) | -$13.08 M(+30.5%) |
| Apr 2012 | - | -$2.58 M(-7.2%) | -$10.03 M(+3.2%) |
| Jan 2012 | - | -$2.78 M(-36.3%) | -$9.71 M(-22.3%) |
| Oct 2011 | - | -$4.36 M(+1330.2%) | -$12.50 M(+35.5%) |
| July 2011 | -$9.22 M(-58.2%) | -$305.00 K(-86.5%) | -$9.22 M(-50.2%) |
| Apr 2011 | - | -$2.27 M(-59.3%) | -$18.50 M(-9.8%) |
| Jan 2011 | - | -$5.56 M(+411.9%) | -$20.50 M(-3.7%) |
| Oct 2010 | - | -$1.09 M(-88.7%) | -$21.28 M(-3.5%) |
| July 2010 | -$22.06 M(+14.8%) | -$9.58 M(+124.7%) | -$22.06 M(+28.4%) |
| Apr 2010 | - | -$4.27 M(-32.7%) | -$17.18 M(+4.9%) |
| Jan 2010 | - | -$6.34 M(+240.5%) | -$16.37 M(+1.1%) |
| Oct 2009 | - | -$1.86 M(-60.4%) | -$16.19 M(-21.1%) |
| July 2009 | -$19.21 M(+29.9%) | -$4.70 M(+35.9%) | -$20.52 M(+3.3%) |
| Apr 2009 | - | -$3.46 M(-43.9%) | -$19.86 M(+3.9%) |
| Jan 2009 | - | -$6.17 M(-0.4%) | -$19.11 M(+5.3%) |
| Oct 2008 | - | -$6.19 M(+53.3%) | -$18.14 M(+22.7%) |
| July 2008 | -$14.79 M(-29.5%) | -$4.04 M(+48.9%) | -$14.79 M(-5.5%) |
| Apr 2008 | - | -$2.71 M(-47.8%) | -$15.65 M(-14.2%) |
| Jan 2008 | - | -$5.20 M(+83.4%) | -$18.24 M(-7.3%) |
| Oct 2007 | - | -$2.83 M(-42.3%) | -$19.69 M(-6.1%) |
| July 2007 | -$20.97 M(+4.0%) | -$4.91 M(-7.4%) | -$20.97 M(-4.4%) |
| Apr 2007 | - | -$5.30 M(-20.2%) | -$21.93 M(+3.2%) |
| Jan 2007 | - | -$6.64 M(+61.6%) | -$21.26 M(+4.2%) |
| Oct 2006 | - | -$4.11 M(-30.0%) | -$20.39 M(+1.2%) |
| July 2006 | -$20.15 M(+95.5%) | -$5.87 M(+26.8%) | -$20.15 M(+10.7%) |
| Apr 2006 | - | -$4.63 M(-19.8%) | -$18.21 M(+10.1%) |
| Jan 2006 | - | -$5.78 M(+49.3%) | -$16.54 M(+37.7%) |
| Oct 2005 | - | -$3.87 M(-1.4%) | -$12.02 M(+16.6%) |
| July 2005 | -$10.31 M(-15.7%) | -$3.93 M(+32.2%) | -$10.30 M(-22.2%) |
| Apr 2005 | - | -$2.97 M(+137.0%) | -$13.25 M(+15.4%) |
| Jan 2005 | - | -$1.25 M(-41.9%) | -$11.47 M(-13.6%) |
| Oct 2004 | - | -$2.16 M(-68.6%) | -$13.29 M(+8.6%) |
| July 2004 | -$12.23 M | -$6.87 M(+473.7%) | -$12.23 M(+17.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2004 | - | -$1.20 M(-60.9%) | -$10.37 M(+37.4%) |
| Jan 2004 | - | -$3.06 M(+178.1%) | -$7.55 M(+202.7%) |
| Oct 2003 | - | -$1.10 M(-78.0%) | -$2.49 M(-157.1%) |
| July 2003 | $4.37 M(-51.4%) | -$5.01 M(-408.4%) | $4.37 M(-59.2%) |
| Apr 2003 | - | $1.62 M(-18.5%) | $10.71 M(-18.4%) |
| Jan 2003 | - | $1.99 M(-65.4%) | $13.12 M(+8.4%) |
| Oct 2002 | - | $5.76 M(+334.5%) | $12.11 M(+34.7%) |
| July 2002 | $8.99 M(-2.6%) | $1.33 M(-67.2%) | $8.99 M(-11.7%) |
| Apr 2002 | - | $4.04 M(+312.7%) | $10.18 M(+16.0%) |
| Jan 2002 | - | $979.00 K(-63.0%) | $8.78 M(-9.9%) |
| Oct 2001 | - | $2.64 M(+4.9%) | $9.74 M(+5.5%) |
| July 2001 | $9.23 M(+81.5%) | $2.52 M(-4.3%) | $9.23 M(+10.2%) |
| Apr 2001 | - | $2.63 M(+35.8%) | $8.38 M(+17.3%) |
| Jan 2001 | - | $1.94 M(-9.2%) | $7.14 M(+15.1%) |
| Oct 2000 | - | $2.14 M(+28.0%) | $6.20 M(+22.4%) |
| July 2000 | $5.08 M(+54.1%) | $1.67 M(+19.4%) | $5.07 M(+18.4%) |
| Apr 2000 | - | $1.40 M(+39.8%) | $4.28 M(+5.0%) |
| Jan 2000 | - | $1.00 M(0.0%) | $4.08 M(+2.5%) |
| Oct 1999 | - | $1.00 M(+13.4%) | $3.98 M(+25.2%) |
| July 1999 | $3.30 M(+312.5%) | $882.00 K(-26.1%) | $3.17 M(+32.7%) |
| Apr 1999 | - | $1.19 M(+32.6%) | $2.39 M(+49.6%) |
| Jan 1999 | - | $900.00 K(+350.0%) | $1.60 M(+77.8%) |
| Oct 1998 | - | $200.00 K(+100.0%) | $900.00 K(+12.5%) |
| July 1998 | $800.00 K(-366.7%) | $100.00 K(-75.0%) | $800.00 K(-20.0%) |
| Apr 1998 | - | $400.00 K(+100.0%) | $1.00 M(+42.9%) |
| Jan 1998 | - | $200.00 K(+100.0%) | $700.00 K(+600.0%) |
| Oct 1997 | - | $100.00 K(-66.7%) | $100.00 K(-133.3%) |
| July 1997 | -$300.00 K(-80.0%) | $300.00 K(+200.0%) | -$300.00 K(-95.2%) |
| Apr 1997 | - | $100.00 K(-125.0%) | -$6.20 M(+26.5%) |
| Jan 1997 | - | -$400.00 K(+33.3%) | -$4.90 M(+19.5%) |
| Oct 1996 | - | -$300.00 K(-94.6%) | -$4.10 M(+46.4%) |
| July 1996 | -$1.50 M(-11.8%) | -$5.60 M(-500.0%) | -$2.80 M(-1500.0%) |
| Apr 1996 | - | $1.40 M(+250.0%) | $200.00 K(-115.4%) |
| Jan 1996 | - | $400.00 K(-60.0%) | -$1.30 M(+44.4%) |
| Oct 1995 | - | $1.00 M(-138.5%) | -$900.00 K(-25.0%) |
| July 1995 | -$1.70 M(+325.0%) | -$2.60 M(+2500.0%) | -$1.20 M(-200.0%) |
| Apr 1995 | - | -$100.00 K(-112.5%) | $1.20 M(+9.1%) |
| Jan 1995 | - | $800.00 K(+14.3%) | $1.10 M(-650.0%) |
| Oct 1994 | - | $700.00 K(-450.0%) | -$200.00 K(-60.0%) |
| July 1994 | -$400.00 K(-92.2%) | -$200.00 K(0.0%) | -$500.00 K(-91.7%) |
| Apr 1994 | - | -$200.00 K(-60.0%) | -$6.00 M(+3.4%) |
| Jan 1994 | - | -$500.00 K(-225.0%) | -$5.80 M(+13.7%) |
| Oct 1993 | - | $400.00 K(-107.0%) | -$5.10 M(0.0%) |
| July 1993 | -$5.10 M(-828.6%) | -$5.70 M(<-9900.0%) | -$5.10 M(-1800.0%) |
| Apr 1993 | - | $0.00(-100.0%) | $300.00 K(-40.0%) |
| Jan 1993 | - | $200.00 K(-50.0%) | $500.00 K(-28.6%) |
| Oct 1992 | - | $400.00 K(-233.3%) | $700.00 K(0.0%) |
| July 1992 | $700.00 K(-126.9%) | -$300.00 K(-250.0%) | $700.00 K(-41.7%) |
| Apr 1992 | - | $200.00 K(-50.0%) | $1.20 M(-1300.0%) |
| Jan 1992 | - | $400.00 K(0.0%) | -$100.00 K(-94.1%) |
| Oct 1991 | - | $400.00 K(+100.0%) | -$1.70 M(-37.0%) |
| July 1991 | -$2.60 M(+23.8%) | $200.00 K(-118.2%) | -$2.70 M(+8.0%) |
| Apr 1991 | - | -$1.10 M(-8.3%) | -$2.50 M(+4.2%) |
| Jan 1991 | - | -$1.20 M(+100.0%) | -$2.40 M(0.0%) |
| Oct 1990 | - | -$600.00 K(-250.0%) | -$2.40 M(+14.3%) |
| July 1990 | -$2.10 M(-47.5%) | $400.00 K(-140.0%) | -$2.10 M(-84.2%) |
| Apr 1990 | - | -$1.00 M(-16.7%) | -$13.30 M(+34.3%) |
| Jan 1990 | - | -$1.20 M(+300.0%) | -$9.90 M(+52.3%) |
| Oct 1989 | - | -$300.00 K(-97.2%) | -$6.50 M(+62.5%) |
| July 1989 | -$4.00 M(+37.9%) | -$10.80 M(-550.0%) | -$4.00 M(+42.9%) |
| Apr 1989 | - | $2.40 M(+9.1%) | -$2.80 M(0.0%) |
| Jan 1989 | - | $2.20 M(0.0%) | -$2.80 M(0.0%) |
| Oct 1988 | - | $2.20 M(-122.9%) | -$2.80 M(-3.4%) |
| July 1988 | -$2.90 M(-6.5%) | -$9.60 M(-500.0%) | -$2.90 M(0.0%) |
| Apr 1988 | - | $2.40 M(+9.1%) | -$2.90 M(-6.5%) |
| Jan 1988 | - | $2.20 M(+4.8%) | -$3.10 M(0.0%) |
| Oct 1987 | - | $2.10 M(-121.9%) | -$3.10 M(0.0%) |
| July 1987 | -$3.10 M(-381.8%) | -$9.60 M(-536.4%) | -$3.10 M(-196.9%) |
| Apr 1987 | - | $2.20 M(0.0%) | $3.20 M(+6.7%) |
| Jan 1987 | - | $2.20 M(+4.8%) | $3.00 M(+87.5%) |
| Oct 1986 | - | $2.10 M(-163.6%) | $1.60 M(+45.5%) |
| July 1986 | $1.10 M(+57.1%) | -$3.30 M(-265.0%) | $1.10 M(+120.0%) |
| Apr 1986 | - | $2.00 M(+150.0%) | $500.00 K(+25.0%) |
| Jan 1986 | - | $800.00 K(-50.0%) | $400.00 K(-63.6%) |
| Oct 1985 | - | $1.60 M(-141.0%) | $1.10 M(+57.1%) |
| July 1985 | $700.00 K(0.0%) | -$3.90 M(-305.3%) | $700.00 K(-74.1%) |
| Apr 1985 | - | $1.90 M(+26.7%) | $2.70 M(+68.8%) |
| Jan 1985 | - | $1.50 M(+25.0%) | $1.60 M(+60.0%) |
| Oct 1984 | - | $1.20 M(-163.2%) | $1.00 M(-600.0%) |
| July 1984 | $700.00 K | -$1.90 M(-337.5%) | -$200.00 K(-111.8%) |
| Apr 1984 | - | $800.00 K(-11.1%) | $1.70 M(+88.9%) |
| Jan 1984 | - | $900.00 K | $900.00 K |
FAQ
- What is Enzo Biochem annual earnings before interest & taxes?
- What is the all time high annual EBIT for Enzo Biochem?
- What is Enzo Biochem annual EBIT year-on-year change?
- What is Enzo Biochem quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Enzo Biochem?
- What is Enzo Biochem quarterly EBIT year-on-year change?
- What is Enzo Biochem TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Enzo Biochem?
- What is Enzo Biochem TTM EBIT year-on-year change?
What is Enzo Biochem annual earnings before interest & taxes?
The current annual EBIT of ENZ is -$9.62 M
What is the all time high annual EBIT for Enzo Biochem?
Enzo Biochem all-time high annual earnings before interest & taxes is $11.48 M
What is Enzo Biochem annual EBIT year-on-year change?
Over the past year, ENZ annual earnings before interest & taxes has changed by +$14.00 M (+59.28%)
What is Enzo Biochem quarterly earnings before interest & taxes?
The current quarterly EBIT of ENZ is -$2.45 M
What is the all time high quarterly EBIT for Enzo Biochem?
Enzo Biochem all-time high quarterly earnings before interest & taxes is $5.76 M
What is Enzo Biochem quarterly EBIT year-on-year change?
Over the past year, ENZ quarterly earnings before interest & taxes has changed by +$1.95 M (+44.40%)
What is Enzo Biochem TTM earnings before interest & taxes?
The current TTM EBIT of ENZ is -$9.62 M
What is the all time high TTM EBIT for Enzo Biochem?
Enzo Biochem all-time high TTM earnings before interest & taxes is $13.12 M
What is Enzo Biochem TTM EBIT year-on-year change?
Over the past year, ENZ TTM earnings before interest & taxes has changed by +$14.78 M (+60.57%)